PANAGIOTIS KATSONIS to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications PANAGIOTIS KATSONIS has written about Xenograft Model Antitumor Assays.
Connection Strength
0.050
-
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer. Nat Med. 2018 05; 24(4):505-511.
Score: 0.027
-
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. Cancer Res. 2015 Apr 01; 75(7):1205-15.
Score: 0.022